54 research outputs found
Determinants of lung function and airway hyperresponsiveness in asthmatic children
SummaryBackgroundAsthma patients exhibit an increased rate of loss of lung function. Determinants to such decline are largely unknown and the modifying effect of steroid therapy is disputed. This cross-sectional study aimed to elucidate factors contributing to such decline and the possible modifying effect of steroid treatment.MethodsWe analyzed determinants of lung function and airway hyperresponsiveness (AHR) in a Scandinavian study of 2390 subjects from 550 families. Families were selected for the presence of two or more asthmatic children as part of a genetic study, Scandinavian Asthma Genetic Study (SAGA).ResultsThe primary analysis studied the association between the lung function and delay of inhaled corticosteroids (ICS) after asthma diagnosis among asthmatic children and young adults with a history of regular ICS treatment (N=919). FEV1 percent predicted (FEV1% pred) was 0.25% lower per year of delay from diagnosis until treatment (p=0.039). This association was significantly greater in allergy skin prick test negative children. There was no significant influence of gender, age at asthma onset, or smoking.In the secondary analysis of the whole population of 2390 asthmatics and non-asthmatics, FEV1% pred was inversely related to having asthmatic siblings (−7.9%; p<0.0001), asthma diagnosis (−2.7%; p=0.0007), smoking (−3.5%; p=0.0027), and positive allergy skin prick test (−0.47% per test; p=0.012), while positively related to being of female gender (1.8%; p=0.0029). Risk of AHR was higher by having asthmatic siblings (OR 2.7; p<0.0001), being of female gender (OR 2.0; p<0.0001), and having asthma (OR 2.0; p<0.0001).ConclusionsThese data suggest that lung function is lower in asthmatics with delayed introduction of ICS therapy, smoking, and positive allergy skin prick test. Lung function is lower and AHR higher in female asthmatics and subjects with asthmatic siblings or established asthma
The instrument suite of the European Spallation Source
An overview is provided of the 15 neutron beam instruments making up the initial instrument suite of the
European Spallation Source (ESS), and being made available to the neutron user community. The ESS neutron
source consists of a high-power accelerator and target station, providing a unique long-pulse time structure
of slow neutrons. The design considerations behind the time structure, moderator geometry and instrument
layout are presented.
The 15-instrument suite consists of two small-angle instruments, two reflectometers, an imaging beamline,
two single-crystal diffractometers; one for macromolecular crystallography and one for magnetism, two powder
diffractometers, and an engineering diffractometer, as well as an array of five inelastic instruments comprising
two chopper spectrometers, an inverse-geometry single-crystal excitations spectrometer, an instrument for vibrational
spectroscopy and a high-resolution backscattering spectrometer. The conceptual design, performance
and scientific drivers of each of these instruments are described.
All of the instruments are designed to provide breakthrough new scientific capability, not currently
available at existing facilities, building on the inherent strengths of the ESS long-pulse neutron source of high
flux, flexible resolution and large bandwidth. Each of them is predicted to provide world-leading performance
at an accelerator power of 2 MW. This technical capability translates into a very broad range of scientific
capabilities. The composition of the instrument suite has been chosen to maximise the breadth and depth
of the scientific impact o
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma a
Preventing Atopic Dermatitis and ALLergies in Children-the PreventADALL study.
Reversing or aborting the increase in allergic and other immune-related non-communicable diseases (NCDs) in the western world, first observed for allergic rhinitis from the 1890ies <sup>1</sup> , requires primary prevention strategies, probably on a general population level. The diseases are likely to be related to changes in lifestyle, environment or both <sup>2</sup> , including reduced microbial diversity, increased use of xenobiotics in industrial and consumer products, exposure to tobacco or nicotinic products and variations in diets and nutritional elements. While some primary allergy preventive strategies may be effective in high risk children <sup>3</sup> , the relevance for preventive strategies on a population level is unclear <sup>4</sup> . This article is protected by copyright. All rights reserved
Directing the future of lung health: the European Respiratory Roadmap.
[No abstract available
Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood
- …